0001209191-24-000818.txt : 20240104
0001209191-24-000818.hdr.sgml : 20240104
20240104164738
ACCESSION NUMBER: 0001209191-24-000818
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karas Eric
CENTRAL INDEX KEY: 0001951287
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 24512819
MAIL ADDRESS:
STREET 1: C/O ARS PHARMACEUTICALS, INC.
STREET 2: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-771-9307
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Silverback Therapeutics, Inc.
DATE OF NAME CHANGE: 20160412
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-02
0
0001671858
ARS Pharmaceuticals, Inc.
SPRY
0001951287
Karas Eric
C/O ARS PHARMACEUTICALS, INC.
11682 EL CAMINO REAL, SUITE 120
SAN DIEGO
CA
92130
0
1
0
0
Chief Commercial Officer
0
Stock option (right to buy)
5.58
2024-01-02
4
A
0
200000
0.00
A
2034-01-01
Common Stock
200000
200000
D
25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.
/s/ Kathleen Scott, Attorney-in-Fact
2024-01-04